Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.

Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.

<h4>Background</h4>Every year approximately 74,000 women die of endometrial cancer, mainly due to recurrent or metastatic disease. The presence of tumor infiltrating lymphocytes (TILs) as well as progesterone receptor (PR) positivity has been correlated with improved prognosis. This stud...

Full description

Bibliographic Details
Main Authors: Paul H van der Horst, Yongyi Wang, Ingrid Vandenput, Liesbeth C Kühne, Patricia C Ewing, Wilfred F J van Ijcken, Marten van der Zee, Frederic Amant, Curt W Burger, Leen J Blok
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22295114/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22295114/?tool=EBI

Similar Items